Arbutus Biopharma
(NASDAQ) ABUS
Arbutus Biopharma Financials at a Glance
Market Cap
$838.60M
Revenue (TTM)
$14.08M
Net Income (TTM)
$33.50M
EPS (TTM)
$-0.18
P/E Ratio
-24.46
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$4.30
Volume
49,914
Open
$4.43
Price
$4.30
Volume
49,914
Open
$4.43
Previous Close
$4.30
Daily Range
$4.29 - $4.48
52-Week Range
$2.71 - $5.10
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$4.30
Volume
49,914
Open
$4.43
Previous Close
$4.30
Daily Range
$4.29 - $4.48
52-Week Range
$2.71 - $5.10
ABUS News
ABUS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Arbutus Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
19
CEO
Lindsay Androski, CFA, MBA
Website
www.arbutusbio.comHeadquarters
Warminster, PA 18974, US
ABUS Financials
Key Financial Metrics (TTM)
Gross Margin
36%
Operating Margin
-3%
Net Income Margin
-2%
Return on Equity
-39%
Return on Capital
-55%
Return on Assets
-35%
Earnings Yield
-4.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$838.60M
Shares Outstanding
195.48M
Volume
49.91K
Short Interest
0.00%
Avg. Volume
2.22M
Financials (TTM)
Gross Profit
$13.72M
Operating Income
$27.05M
EBITDA
$26.69M
Operating Cash Flow
$39.64M
Capital Expenditure
$0.00
Free Cash Flow
$39.64M
Cash & ST Invst.
$91.47M
Total Debt
$4.19M
Arbutus Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.05M
-33.2%
Gross Profit
$1.04M
+114.4%
Gross Margin
98.95%
N/A
Market Cap
$838.60M
N/A
Market Cap/Employee
$19.06M
N/A
Employees
44
N/A
Net Income
$3.76M
+70.0%
EBITDA
$7.63M
+50.2%
Quarterly Fundamentals
Net Cash
$87.28M
-28.1%
Accounts Receivable
$1.75M
-27.5%
Inventory
$0.00
N/A
Long Term Debt
$3.64M
+351.7%
Short Term Debt
$547.00K
+13.3%
Return on Assets
-35.41%
N/A
Return on Invested Capital
-55.42%
N/A
Free Cash Flow
$4.68M
+55.0%
Operating Cash Flow
$4.68M
+54.6%